Skip to search formSkip to main contentSkip to account menu

MORAb-009 monoclonal antibody

Known as: MORAb-009 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Monoclonal Antibodies

Narrower (1)

amatuximab
mesothelin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Tumor and organ uptake of (64)Cu-labeled MORAb-009 (amatuximab), an anti-mesothelin antibody, by PET imaging and biodistribution studies.
2015
2015
Tumor and organ uptake of 64Cu labeled MORAb-009, an anti-mesothelin antibody by PET Imaging and biodistribution studies
2012
2012
Characterization of crystals of an antibody-recognition fragment of the cancer differentiation antigen mesothelin in complex with the therapeutic antibody MORAb-009.
The mesothelin-specific monoclonal antibody MORAb-009 is capable of blocking the binding of mesothelin to CA-125 and displays… 
2012
2012
[Table, 111In-Labeled CHX-A''-DTPA–conjugated MORAb-009, a chimeric monoclonal antibody directed against mesothelin].
2011
2011
Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody.
2010
2010
Optimization of MORAb-009 dose to block shed antigen in circulation and produce high tumor to background ratios of In-111 MORAb-009
2010
2010
A preclinical evaluation of mesothelin-specific tumor imaging using 111In-CHX-A"-MORAb-009, a chimeric monoclonal antibody
2008
2008
A phase I study of MORab-009, a monoclonal antibody against mesothelin, in mesothelioma, pancreatic and ovarian cancer
3578 Background: MORAb-009 is a monoclonal antibody that targets mesothelin, a cell surface adhesion protein over-expressed in… 
2007
2007
A phase 1 study of MORAb-009, a monoclonal antibody against mesothelin in pancreatic cancer, mesothelioma and ovarian adenocarcinoma
14041 Background: MORAb-009 is a monoclonal antibody that targets mesothelin, a cell surface adhesive protein overexpressed in… 
2007
2007
MORAb-009, a monoclonal antibody that specifically targets mesothelin, a cell surface tumor adhesion molecule over-expressed in pancreatic, ovarian, and lung cancer and mesothelioma.
654 Background: Mesothelin is a glycosyl-phosphatidyl inositol-linked membrane protein that is consistently over-expressed in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)